AMCR Amcor plc
Amcor plc, together with its subsidiaries, develops and produces packaging solutions for nutrition, health, beauty, and wellness categories in Europe, North America, Latin America, and the Asia Pacific. Its products include apparel, applicators, bags and bulk bags, bottles and vials, building materials, canisters and jerrycans, drinking cups, films and laminates, jars, lids, tapes and adhesives, trays, tubes, wipes packaging solutions, and miscellaneous and accessories, as well as tubs and pots. The company's Global Flexible Packaging Solutions segment develops and supplies flexible packaging; and supplies polymer resin, aluminum, and fiber based flexible packaging solutions. Its Global Rigid Packaging Solutions segment manufactures rigid packaging containers, closures, dispensing and pharma delivery devices, and related products. The company sells its products through its direct sales force. Amcor plc was incorporated in 1926 and is headquartered in Zurich, Switzerland.…
Industry Peers
Packaging & ContainersKey Statistics
About Amcor (NYSE: AMCR)
›
Amcor (NYSE: AMCR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Packaging & Containers industry, part of the Consumer Cyclical sector, and reports about 75,000 employees.
The shares were at 42.46 USD on 19 November 2026, up 3.4% over 52 weeks. Its 52-week range is 36.25 USD to 50.94 USD: the price is 16.6% below the high and 17.1% above the low.
At a market capitalisation of 19.61B USD, it trades at 18.2 times trailing earnings and 10.2 times forward earnings. The median trailing P/E of its 16 largest Packaging & Containers peers is 19.2, so AMCR is valued in line with them. It pays a dividend yielding 6.04% (it pays out 112% of its earnings), against a median of 2.64% among the dividend payers in that peer group.
Amcor reports return on equity of 9.4%, an operating margin of 8.7% and revenue up 6.7% year over year.
Its debt exceeds its cash by 14.90B USD, a debt-to-equity ratio of 1.26. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 49.07 USD is 15.6% above the current price. The next earnings report is expected on 2 February 2027.